Publication | Closed Access

Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study

Chemotherapy Versus ChemotherapyOncologyPlatinum-refractory Ovarian CancerMedicineMetronomic TherapyGynecologyPharmacotherapyCancer TreatmentJavelin Ovarian 200PharmacologyGynecology OncologyOvarian Cancer